Publications

  1. Beutler AS, Kulkarni AA, Kanwar R, Klein CJ, Therneau TM, Qin R, Banck MS, Boora GK, Ruddy KJ, Wu Y, Smalley RL, Cunningham JM, Le-Lindqwister NA, Beyerlein P, Schroth GP, Windebank AJ, Zuchner S, Loprinzi CL. Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy. Ann Neurol. 2014 Aug 28.
    View PubMed
  2. Pachman DR, Watson JC, Loprinzi CL. Therapeutic Strategies for Cancer Treatment Related Peripheral Neuropathies. Curr Treat Options Oncol. 2014 Aug 14.
    View PubMed
  3. Pachman DR, Watson JC, Lustberg MB, Wagner-Johnston ND, Chan A, Broadfield L, Cheung YT, Steer C, Storey DJ, Chandwani KD, Paice J, Jean-Pierre P, Oh J, Kamath J, Fallon M, Strik H, Koeppen S, Loprinzi CL. Management options for established chemotherapy-induced peripheral neuropathy. Support Care Cancer. 2014 Aug; 22(8):2281-95. Epub 2014 May 31.
    View PubMed
  4. Barton DL, Thanarajasingam G, Sloan JA, Diekmann B, Fuloria J, Kottschade LA, Lyss AP, Jaslowski AJ, Mazurczak MA, Blair SC, Terstriep S, Loprinzi CL. Phase III double-blind, placebo-controlled study of gabapentin for the prevention of delayed chemotherapy-induced nausea and vomiting in patients receiving highly emetogenic chemotherapy, NCCTG N08C3 (Alliance). Cancer. 2014 Jul 09.
    View PubMed
  5. Hegerova LT, Leal AD, Grendahl DC, Seisler DK, Sorgatz KM, Anderson KJ, Hilger CR, Loprinzi CL. An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy. Support Care Cancer. 2014 Jun 26.
    View PubMed
  6. Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL, American Society of Clinical Oncology. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol. 2014 Jun 20; 32(18):1941-67. Epub 2014 Apr 14
    View PubMed
  7. Leal AD, Qin R, Atherton PJ, Haluska P, Behrens RJ, Tiber CH, Watanaboonyakhet P, Weiss M, Adams PT, Dockter TJ, Loprinzi CL, Alliance for Clinical Trials in Oncology. North Central Cancer Treatment Group/Alliance trial N08CA-the use of glutathione for prevention of paclitaxel/carboplatin-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled study. Cancer. 2014 Jun 15; 120(12):1890-7. Epub 2014 Mar 11.
    View PubMed
  8. Kadakia KC, Rozell SA, Butala AA, Loprinzi CL. Supportive Cryotherapy: A Review From Head to Toe. J Pain Symptom Manage. 2014 Jun; 47(6):1100-15. Epub 2013 Nov 07.
    View PubMed
  9. Leenstra JL, Miller RC, Qin R, Martenson JA, Dornfeld KJ, Bearden JD, Puri DR, Stella PJ, Mazurczak MA, Klish MD, Novotny PJ, Foote RL, Loprinzi CL. Doxepin rinse versus placebo in the treatment of acute oral mucositis pain in patients receiving head and neck radiotherapy with or without chemotherapy: a phase III, randomized, double-blind trial (NCCTG-N09C6 [Alliance]). J Clin Oncol. 2014 May 20; 32(15):1571-7. Epub 2014 Apr 14.
    View PubMed
  10. Leal AD, Kadakia KC, Looker S, Hilger C, Sorgatz K, Anderson K, Jacobson A, Grendahl D, Seisler D, Hobday T, Loprinzi CL. Fosaprepitant-induced phlebitis: a focus on patients receiving doxorubicin/cyclophosphamide therapy. Support Care Cancer. 2014 May; 22(5):1313-7. Epub 2014 Jan 09.
    View PubMed
  11. Loprinzi CL, Qin R, Dakhil SR, Fehrenbacher L, Flynn KA, Atherton P, Seisler D, Qamar R, Lewis GC, Grothey A. Phase III randomized, placebo-controlled, double-blind study of intravenous calcium and magnesium to prevent oxaliplatin-induced sensory neurotoxicity (N08CB/Alliance). J Clin Oncol. 2014 Apr 1; 32(10):997-1005. Epub 2013 Dec 02.
    View PubMed
  12. Kadakia KC, Leal AD, Seisler DK, Qin R, Fee-Schroeder KC, Grendahl DC, Sorgatz KM, Loprinzi CL. Antiemetic prescribing practices using a computerized physician order entry system. Support Care Cancer. 2014 Jan; 22(1):217-23. Epub 2013 Sep 13.
    View PubMed
  13. Pachman DR, Loprinzi CL, Grothey A, Ta LE. The search for treatments to reduce chemotherapy-induced peripheral neuropathy. J Clin Invest. 2014 Jan; 124(1):72-4.
  14. Loprinzi C. Chemotherapy-induced nausea and vomiting (cinv): Perceptions, mechanisms, and treatment guidelines. Journal of Managed Care Medicine. 2014; 17(2):45-9.
  15. Jones D, Zhao F, Brell J, Lewis MA, Loprinzi CL, Weiss M, Fisch MJ. Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer. J Cancer Surviv. 2014(Epub ahead of print).
  16. Meyerhardt JA, Mangu PB, Flynn PJ, Korde L, Loprinzi CL, Minsky BD, Petrelli NJ, Ryan K, Schrag DH, Wong SL, Benson AB 3rd, American Society of Clinical Oncology. Follow-up care, surveillance protocol, and secondary prevention measures for survivors of colorectal cancer: American Society of Clinical Oncology clinical practice guideline endorsement. J Clin Oncol. 2013 Dec 10; 31(35):4465-70. Epub 2013 Nov 12.
    View PubMed
  17. Staff NP, Podratz JL, Grassner L, Bader M, Paz J, Knight AM, Loprinzi CL, Trushina E, Windebank AJ. Bortezomib alters microtubule polymerization and axonal transport in rat dorsal root ganglion neurons. Neurotoxicology. 2013 Dec; 39:124-31. Epub 2013 Sep 12.
    View PubMed
  18. Lavoie Smith EM, Barton DL, Qin R, Steen PD, Aaronson NK, Loprinzi CL. Assessing patient-reported peripheral neuropathy: the reliability and validity of the european organization for research and treatment of cancer qlq-cipn20 questionnaire. Qual Life Res. 2013 Dec; 22(10):2787-99.
  19. Pachman DR, Loprinzi CL, Novotny PJ, Satele DV, Linquist BM, Wolf S, Barton DL. Sternal skin conductance: a reasonable surrogate for hot flash measurement? Menopause. 2013 Nov; 20(11):1164-8.
    View PubMed
  20. Brown LC, Atherton PJ, Neben-Wittich MA, Wender DB, Behrens RJ, Kozelsky TF, Loprinzi CL, Haddock MG, Martenson JA. Assessment of long-term rectal function in patients who received pelvic radiotherapy: a pooled North Central Cancer Treatment Group trial analysis, N09C1. Support Care Cancer. 2013 Oct; 21(10):2869-77. Epub 2013 Jun 08.
    View PubMed
  21. Barton DL, Liu H, Dakhil SR, Linquist B, Sloan JA, Nichols CR, McGinn TW, Stella PJ, Seeger GR, Sood A, Loprinzi CL. Wisconsin Ginseng (Panax quinquefolius) to improve cancer-related fatigue: a randomized, double-blind trial, N07C2. J Natl Cancer Inst. 2013 Aug 21; 105(16):1230-8. Epub 2013 Jul 13.
    View PubMed
  22. Stan D, Loprinzi CL, Ruddy KJ. Breast cancer survivorship issues. Hematol Oncol Clin North Am. 2013 Aug; 27(4):805-27, ix. Epub 2013 Jun 19.
    View PubMed
  23. Thompson CA, Hugo SE, Swetz KM, Novotny PJ, Sloan JA, Loprinzi CL, Moynihan TJ, Shanafelt TD. End-of-life care in a population-based cohort of cancer patients: clinical trial participation versus standard of care. BMJ Support Palliat Care. 2013 Jun; 3(2):181-7. Epub 2013 Mar 09.
    View PubMed
  24. Barton DL, Burger K, Novotny PJ, Fitch TR, Kohli S, Soori G, Wilwerding MB, Sloan JA, Kottschade LA, Rowland KM Jr, Dakhil SR, Nikcevich DA, Loprinzi CL. The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9. Support Care Cancer. 2013 Apr; 21(4):1185-92. Epub 2012 Nov 13.
    View PubMed
  25. Roeland E, Loprinzi C, Moynihan TJ, Smith TJ, Temel J. In chemotherapy for lung cancer, sometimes less is more. J Natl Compr Canc Netw. 2013 Mar 1; 11(3):232-5.
    View PubMed
  26. Limburg PJ, Mandrekar SJ, Aubry MC, Ziegler KL, Zhang J, Yi JE, Henry M, Tazelaar HD, Lam S, McWilliams A, Midthun DE, Edell ES, Rickman OB, Mazzone P, Tockman M, Beamis JF, Lamb C, Simoff M, Loprinzi C, Szabo E, Jett J, Cancer Prevention Network. Randomized phase II trial of sulindac for lung cancer chemoprevention. Lung Cancer. 2013 Mar; 79(3):254-61. Epub 2012 Dec 20.
    View PubMed
  27. Sood R, Sood A, Wolf SL, Linquist BM, Liu H, Sloan JA, Satele DV, Loprinzi CL, Barton DL. Paced breathing compared with usual breathing for hot flashes. Menopause. 2013 Feb; 20(2):179-84.
    View PubMed
  28. Peterson DE, Ohrn K, Bowen J, Fliedner M, Lees J, Loprinzi C, Mori T, Osaguona A, Weikel DS, Elad S, Lalla RV, Mucositis Study Group of the Multinational Association of Supportive Care in Cancer/International Society of Oral Oncology (MASCC/ISOO). Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer. 2013 Jan; 21(1):327-32. Epub 2012 Sep 21.
    View PubMed
  29. Ta LE, Schmelzer JD, Bieber AJ, Loprinzi CL, Sieck GC, Brederson JD, Low PA, Windebank AJ. A novel and selective poly (ADP-ribose) polymerase inhibitor ameliorates chemotherapy-induced painful neuropathy. PLoS One. 2013; 8(1):e54161. Epub 2013 Jan 10.
    View PubMed
  30. Peethambaram P, Olson J, Loprinzi CL. Soyfood consumption in breast cancer survivors: Don't overstate the facts! ONCOLOGY (United States). 2013; 27(5).
  31. Loprinzi C. Chemotherapy-induced nausea and vomiting (CINV): Perceptions, mechanisms, and treatment guidelines. Journal of Managed Care Medicine. 2013; 16(2):27-30.
  32. Pachman DR, Barton DL, Swetz KM, Loprinzi CL. Troublesome symptoms in cancer survivors: fatigue, insomnia, neuropathy, and pain. J Clin Oncol. 2012 Oct 20; 30(30):3687-96. Epub 2012 Sep 24.
    View PubMed
  33. Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, Le-Lindqwister NA, Soori GS, Jaslowski AJ, Kelaghan J, Novotny PJ, Lachance DH, Loprinzi CL. Further data supporting that paclitaxel-associated acute pain syndrome is associated with development of peripheral neuropathy: North Central Cancer Treatment Group trial N08C1. Cancer. 2012 Oct 15; 118(20):5171-8. Epub 2012 Mar 13.
    View PubMed
  34. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20(8):1729-35. Epub 2011 Sep 16.
    View PubMed
  35. Atherton PJ, Burger KN, Loprinzi CL, Neben Wittich MA, Miller RC, Jatoi A, Sloan JA. Using the Skindex-16 and Common Terminology Criteria for Adverse Events to assess rash symptoms: results of a pooled-analysis (N0993). Support Care Cancer. 2012 Aug; 20(8):1729-35. Epub 2011 Sep 16.
    View PubMed
  36. Loprinzi PD, Cardinal BJ, Winters-Stone K, Smit E, Loprinzi CL. Physical activity and the risk of breast cancer recurrence: a literature review. Oncol Nurs Forum. 2012 May 1; 39(3):269-74.
    View PubMed
  37. Kadakia KC, Barton DL, Loprinzi CL, Sloan JA, Otley CC, Diekmann BB, Novotny PJ, Alberts SR, Limburg PJ, Pittelkow MR. Randomized controlled trial of acitretin versus placebo in patients at high-risk for basal cell or squamous cell carcinoma of the skin (North Central Cancer Treatment Group Study 969251). Cancer. 2012 Apr 15; 118(8):2128-37. Epub 2011 Aug 31.
    View PubMed
  38. Kadakia KC, Moynihan TJ, Smith TJ, Loprinzi CL. Palliative communications: addressing chemotherapy in patients with advanced cancer. Ann Oncol. 2012 Apr; 23(Suppl 3):29-32.
    View PubMed
  39. Jones JM, Kohli M, Loprinzi CL. Androgen deprivation therapy-associated vasomotor symptoms. Asian J Androl. 2012 Mar; 14(2):193-7. Epub 2012 Jan 30.
    View PubMed
  40. Wolf SL, Barton DL, Qin R, Wos EJ, Sloan JA, Liu H, Aaronson NK, Satele DV, Mattar BI, Green NB, Loprinzi CL. The relationship between numbness, tingling, and shooting/burning pain in patients with chemotherapy-induced peripheral neuropathy (CIPN) as measured by the EORTC QLQ-CIPN20 instrument, N06CA. Support Care Cancer. 2012 Mar; 20(3):625-32. Epub 2011 Apr 12.
    View PubMed
  41. Pachman DR, Barton DL, Clayton AC, McGovern RM, Jefferies JA, Novotny PJ, Sloan JA, Loprinzi CL, Gostout BS. Randomized clinical trial of imiquimod: an adjunct to treating cervical dysplasia. Am J Obstet Gynecol. 2012 Jan; 206(1):42.e1-7. Epub 2011 Jul 13.
    View PubMed
  42. Pruthi S, Qin R, Terstreip SA, Liu H, Loprinzi CL, Shah TR, Tucker KF, Dakhil SR, Bury MJ, Carolla RL, Steen PD, Vuky J, Barton DL. A phase III, randomized, placebo-controlled, double-blind trial of flaxseed for the treatment of hot flashes: North Central Cancer Treatment Group N08C7. Menopause. 2012 Jan; 19(1):48-53.
    View PubMed
  43. Moraska AR, Moraska JM, Sideras K, Loprinzi CL. Management of hot flashes in breast cancer patients. European J Clin Med Oncol. 2012; 4(1):1-9.
  44. Jatoi A, Nieva JJ, Qin R, Loprinzi CL, Wos EJ, Novotny PJ, Moore DF Jr, Mowat RB, Bechar N, Pajon ER Jr, Hartmann LC. A pilot study of long-acting octreotide for symptomatic malignant ascites. Oncology. 2012; 82(6):315-20. Epub 2012 May 10.
    View PubMed
  45. Sandhu NP, Mac Bride MB, Dilaveri CA, Neal L, Farley DR, Loprinzi CL, Wahner-Roedler DL, Ghosh K. Male breast cancer. Journal of Men's Health. 2012; 9(3):146-53.
  46. Loprinzi CE, Prasad K, Schroeder DR, Sood A. Stress Management and Resilience Training (SMART) program to decrease stress and enhance resilience among breast cancer survivors: a pilot randomized clinical trial. Clin Breast Cancer. 2011 Dec; 11(6):364-8. Epub 2011 Aug 10
    View PubMed
  47. Kottschade LA, Sloan JA, Mazurczak MA, Johnson DB, Murphy BP, Rowland KM, Smith DA, Berg AR, Stella PJ, Loprinzi CL. The use of vitamin E for the prevention of chemotherapy-induced peripheral neuropathy: results of a randomized phase III clinical trial. Support Care Cancer. 2011 Nov; 19(11):1769-77. Epub 2010 Oct 09.
    View PubMed
  48. Neben-Wittich MA, Atherton PJ, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Loprinzi CL, Burger KN, Martenson JA, Miller RC. Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast radiotherapy: the North Central Cancer Treatment Group (N06C4). Int J Radiat Oncol Biol Phys. 2011 Oct 1; 81(2):397-402. Epub 2010 Oct 01.
    View PubMed
  49. Jatoi A, Dakhil SR, Sloan JA, Kugler JW, Rowland KM Jr, Schaefer PL, Novotny PJ, Wender DB, Gross HM, Loprinzi CL, North Central Cancer Treatment Group. Prophylactic tetracycline does not diminish the severity of epidermal growth factor receptor (EGFR) inhibitor-induced rash: results from the North Central Cancer Treatment Group (Supplementary N03CB). Support Care Cancer. 2011 Oct; 19(10):1601-7. Epub 2010 Sep 6
    View PubMed
  50. Gill S, Loprinzi C, Kennecke H, Grothey A, Nelson G, Woods R, Speers C, Alberts SR, Bardia A, O'Connell MJ, Sargent DJ. Prognostic web-based models for stage II and III colon cancer: A population and clinical trials-based validation of numeracy and adjuvant! online. Cancer. 2011 Sep 15; 117(18):4155-65. Epub 2011 Mar 01.
    View PubMed
  51. Pachman DR, Barton DL, Watson JC, Loprinzi CL. Chemotherapy-induced peripheral neuropathy: prevention and treatment. Clin Pharmacol Ther. 2011 Sep; 90(3):377-87. Epub 2011 Aug 03.
    View PubMed
  52. Jones JM, Qin R, Bardia A, Linquist B, Wolf S, Loprinzi CL. Antiemetics for chemotherapy-induced nausea and vomiting occurring despite prophylactic antiemetic therapy. J Palliat Med. 2011 Jul; 14(7):810-4. Epub 2011 May 09.
    View PubMed
  53. Pachman DR, Barton D, Carns PE, Novotny PJ, Wolf S, Linquist B, Kohli S, Smith DR, Loprinzi CL. Pilot evaluation of a stellate ganglion block for the treatment of hot flashes. Support Care Cancer. 2011 Jul; 19(7):941-7. Epub 2010 May 23.
    View PubMed
  54. Barton DL, Wos EJ, Qin R, Mattar BI, Green NB, Lanier KS, Bearden JD 3rd, Kugler JW, Hoff KL, Reddy PS, Rowland KM Jr, Riepl M, Christensen B, Loprinzi CL. A double-blind, placebo-controlled trial of a topical treatment for chemotherapy-induced peripheral neuropathy: NCCTG trial N06CA. Support Care Cancer. 2011 Jun; 19(6):833-41. Epub 2010 May 25.
    View PubMed
  55. Loprinzi CL, Balcueva EP, Liu H, Sloan JA, Kottschade LA, Stella PJ, Carlson MD, Moore DF Jr, Zon RT, Levitt R, Jaslowski AJ. A phase III randomized, double-blind, placebo-controlled study of pilocarpine for vaginal dryness: North Central Cancer Treatment group study N04CA. J Support Oncol. 2011 May-Jun; 9(3):105-12.
    View PubMed
  56. Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011 May; 12(5):489-95. Epub 2011 Feb 04.
    View PubMed
  57. Loprinzi CL, Reeves BN, Dakhil SR, Sloan JA, Wolf SL, Burger KN, Kamal A, Le-Lindqwister NA, Soori GS, Jaslowski AJ, Novotny PJ, Lachance DH. Natural history of paclitaxel-associated acute pain syndrome: prospective cohort study NCCTG N08C1. J Clin Oncol. 2011 Apr 10; 29(11):1472-8. Epub 2011 Mar 07.
    View PubMed
  58. Miller RC, Schwartz DJ, Sloan JA, Griffin PC, Deming RL, Anders JC, Stoffel TJ, Haselow RE, Schaefer PL, Bearden JD 3rd, Atherton PJ, Loprinzi CL, Martenson JA. Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Cancer Treatment Group N06C4. Int J Radiat Oncol Biol Phys. 2011 Apr 1; 79(5):1460-6. Epub 2010 Aug 26.
    View PubMed
  59. Grothey A, Nikcevich DA, Sloan JA, Kugler JW, Silberstein PT, Dentchev T, Wender DB, Novotny PJ, Chitaley U, Alberts SR, Loprinzi CL. Intravenous calcium and magnesium for oxaliplatin-induced sensory neurotoxicity in adjuvant colon cancer: NCCTG N04C7. J Clin Oncol. 2011 Feb 1; 29(4):421-7. Epub 2010 Dec 28.
    View PubMed
  60. Steensma DP, Sloan JA, Dakhil SR, Dalton R, Kahanic SP, Prager DJ, Stella PJ, Rowland KM Jr, Novotny PJ, Loprinzi CL. Phase III, randomized study of the effects of parenteral iron, oral iron, or no iron supplementation on the erythropoietic response to darbepoetin alfa for patients with chemotherapy-associated anemia. J Clin Oncol. 2011 Jan 1; 29(1):97-105. Epub 2010 Nov 22.
    View PubMed
  61. Barton DL, Atherton PJ, Bauer BA, Moore DF Jr, Mattar BI, Lavasseur BI, Rowland KM Jr, Zon RT, Lelindqwister NA, Nagargoje GG, Morgenthaler TI, Sloan JA, Loprinzi CL. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J Support Oncol. 2011 Jan-Feb; 9(1):24-31.
    View PubMed
  62. Kamal AH, Loprinzi CL, Reynolds C, Dueck AC, Geiger XJ, Ingle JN, Carlson RW, Hobday TJ, Winer EP, Goetz MP. Breast medical oncologists' use of standard prognostic factors to predict a 21-gene recurrence score. Oncologist. 2011; 16(10):1359-66. Epub 2011 Sep 20.
    View PubMed
  63. Wolf SL, Qin R, Menon SP, Rowland KM Jr, Thomas S, Delaune R, Christian D, Pajon ER Jr, Satele DV, Berenberg JL, Loprinzi CL, North Central Cancer Treatment Group Study N05C5. Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. J Clin Oncol. 2010 Dec 10; 28(35):5182-7. Epub 2010 Nov 08.
    View PubMed
  64. Wolf SL, Qin R, Menon SP, Rowland KM Jr, Thomas S, Delaune R, Christian D, Pajon ER Jr, Satele DV, Berenberg JL, Loprinzi CL, North Central Cancer Treatment Group Study N05C5. Placebo-controlled trial to determine the effectiveness of a urea/lactic acid-based topical keratolytic agent for prevention of capecitabine-induced hand-foot syndrome: North Central Cancer Treatment Group Study N05C5. J Clin Oncol. 2010 Dec 10; 28(35):5182-7. Epub 2010 Nov 08.
    View PubMed
  65. Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ. Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol. 2010 Dec 10; 28(35):5147-52. Epub 2010 Nov 08.
    View PubMed
  66. Sideras K, Loprinzi CL. Nonhormonal management of hot flashes for women on risk reduction therapy. J Natl Compr Canc Netw. 2010 Oct; 8(10):1171-9.
    View PubMed
  67. Loprinzi CL, Schapira L, Moynihan T, Kalemkerian GP, von Gunten C, Steensma D. Compassionate honesty. J Palliat Med. 2010 Oct; 13(10):1187-91.
    View PubMed
  68. Moraska AR, Sood A, Dakhil SR, Sloan JA, Barton D, Atherton PJ, Suh JJ, Griffin PC, Johnson DB, Ali A, Silberstein PT, Duane SF, Loprinzi CL. Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05C7 trial. J Clin Oncol. 2010 Aug 10; 28(23):3673-9. Epub 2010 Jul 12.
    View PubMed
  69. Barton DL, LaVasseur BI, Sloan JA, Stawis AN, Flynn KA, Dyar M, Johnson DB, Atherton PJ, Diekmann B, Loprinzi CL. Phase III, placebo-controlled trial of three doses of citalopram for the treatment of hot flashes: NCCTG trial N05C9. J Clin Oncol. 2010 Jul 10; 28(20):3278-83. Epub 2010 May 24.
    View PubMed
  70. Sideras K, Ingle JN, Ames MM, Loprinzi CL, Mrazek DP, Black JL, Weinshilboum RM, Hawse JR, Spelsberg TC, Goetz MP. Coprescription of tamoxifen and medications that inhibit CYP2D6. J Clin Oncol. 2010 Jun 1; 28(16):2768-76. Epub 2010 May 03.
    View PubMed
  71. Jatoi A, Ritter HL, Dueck A, Nguyen PL, Nikcevich DA, Luyun RF, Mattar BI, Loprinzi CL. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer. 2010 May; 68(2):234-9. Epub 2009 Aug 08.
    View PubMed
  72. Moraska AR, Atherton PJ, Szydlo DW, Barton DL, Stella PJ, Rowland KM Jr, Schaefer PL, Krook J, Bearden JD, Loprinzi CL. Gabapentin for the management of hot flashes in prostate cancer survivors: a longitudinal continuation Study-NCCTG Trial N00CB. J Support Oncol. 2010 May-Jun; 8(3):128-32.
    View PubMed
  73. Hines SL, Sloan JA, Atherton PJ, Perez EA, Dakhil SR, Johnson DB, Reddy PS, Dalton RJ, Mattar BI, Loprinzi CL. Zoledronic acid for treatment of osteopenia and osteoporosis in women with primary breast cancer undergoing adjuvant aromatase inhibitor therapy. Breast. 2010 Apr; 19(2):92-6. Epub 2010 Jan 15.
    View PubMed
  74. Kearns AE, Northfelt DW, Dueck AC, Atherton PJ, Dakhil SR, Rowland KM Jr, Fuloria J, Flynn PJ, Dentchev T, Loprinzi CL. Osteoporosis prevention in prostate cancer patients receiving androgen ablation therapy: placebo-controlled double-blind study of estradiol and risedronate: N01C8. Support Care Cancer. 2010 Mar; 18(3):321-8. Epub 2009 May 27.
    View PubMed
  75. Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN. Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol. 2010 Feb 1; 28(4):641-7. Epub 2009 Nov 09.
    View PubMed
  76. Barton DL, Soori GS, Bauer BA, Sloan JA, Johnson PA, Figueras C, Duane S, Mattar B, Liu H, Atherton PJ, Christensen B, Loprinzi CL. Pilot study of Panax quinquefolius (American ginseng) to improve cancer-related fatigue: a randomized, double-blind, dose-finding evaluation: NCCTG trial N03CA. Support Care Cancer. 2010 Feb; 18(2):179-87. Epub 2009 May 06.
    View PubMed
  77. Croghan IT, Hurt RD, Ebbert JO, Croghan GA, Polk OD, Stella PJ, Novotny PJ, Sloan J, Loprinzi CL. Racial differences in smoking abstinence rates in a multicenter, randomized, open-label trial in the United States. Z Gesundh Wiss. 2010 Feb; 18(1):59-68. Epub 2009 Aug 11.
    View PubMed
  78. Bardia A, Loprinzi C, Grothey A, Nelson G, Alberts S, Menon S, Thome S, Gill S, Sargent D. Adjuvant chemotherapy for resected stage II and III colon cancer: comparison of two widely used prognostic calculators. Semin Oncol. 2010 Feb; 37(1):39-46.
    View PubMed
  79. Ta LE, Bieber AJ, Carlton SM, Loprinzi CL, Low PA, Windebank AJ. Transient Receptor Potential Vanilloid 1 is essential for cisplatin-induced heat hyperalgesia in mice. Mol Pain. 2010; 6:15. Epub 2010 Mar 05.
    View PubMed
  80. Pachman DR, Jones JM, Loprinzi CL. Management of menopause-associated vasomotor symptoms: Current treatment options, challenges and future directions. Int J Womens Health. 2010; 2:123-35. Epub 2010 Aug 09.
    View PubMed
  81. Jatoi A, Thrower A, Sloan JA, Flynn PJ, Wentworth-Hartung NL, Dakhil SR, Mattar BI, Nikcevich DA, Novotny P, Sekulic A, Loprinzi CL. Does sunscreen prevent epidermal growth factor receptor (EGFR) inhibitor-induced rash? Results of a placebo-controlled trial from the North Central Cancer Treatment Group (N05C4). Oncologist. 2010; 15(9):1016-22. Epub 2010 Aug 26.
    View PubMed
  82. Bennett GJ, Grothey A, Loprinzi CL. Peripheral neurotoxicities. J Support Oncol. 2010; 8(2, suppl 1):22-3.
    View PubMed
  83. Loprinzi CL. Primary care providers uneasy on care for cancer survivorship: Commentary. Oncol. Rep. 2010; (Mar-Apr):42.
    View PubMed
  84. Loprinzi CL. Vaginal estrogen therapy causes jump in serum estradiol level: Commentary. Oncol. Rep. 2010; (Mar-Apr):44.
    View PubMed
  85. Loprinzi CL. Stellate ganglion block may ease severe, refractory hot flashes: Commentary. Oncol. Rep. 2010; (Mar-Apr):44.
    View PubMed
  86. Loprinzi CL. Cancer and diarrhea: Rising incidence of an old problem - Commentary. Oncol. Rep. 2010; (Mar-Apr):45.
    View PubMed
  87. Hines SL, Mincey B, Dentchev T, Sloan JA, Perez EA, Johnson DB, Schaefer PL, Alberts S, Liu H, Kahanic S, Mazurczak MA, Nikcevich DA, Loprinzi CL. Immediate versus delayed zoledronic acid for prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen-N03CC. Breast Cancer Res Treat. 2009 Oct; 117(3):603-9. Epub 2009 Feb 12.
    View PubMed
  88. Katipamula R, Degnim AC, Hoskin T, Boughey JC, Loprinzi C, Grant CS, Brandt KR, Pruthi S, Chute CG, Olson JE, Couch FJ, Ingle JN, Goetz MP. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative magnetic resonance imaging. J Clin Oncol. 2009 Sep 1; 27(25):4082-8. Epub 2009 Jul 27.
    View PubMed
  89. Loprinzi CL, Diekmann B, Novotny PJ, Stearns V, Sloan JA. Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause. 2009 Sep-Oct; 16(5):883-7.
    View PubMed
  90. Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P. Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol. 2009 Jun 10; 27(17):2831-7. Epub 2009 Mar 30.
    View PubMed
  91. Bardia A, Novotny P, Sloan J, Barton D, Loprinzi C. Efficacy of nonestrogenic hot flash therapies among women stratified by breast cancer history and tamoxifen use: a pooled analysis. Menopause. 2009 May-Jun; 16(3):477-83.
    View PubMed
  92. Cheville AL, Sloan JA, Northfelt DW, Jillella AP, Wong GY, Bearden Iii Jd, Liu H, Schaefer PL, Marchello BT, Christensen BJ, Loprinzi CL. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer. 2009 Apr; 17(4):451-60. Epub 2009 Jan 13.
    View PubMed
  93. Hines SL, Mincey BA, Sloan JA, Thomas SP, Chottiner E, Loprinzi CL, Carlson MD, Atherton PJ, Salim M, Perez EA. Phase III randomized, placebo-controlled, double-blind trial of risedronate for the prevention of bone loss in premenopausal women undergoing chemotherapy for primary breast cancer. J Clin Oncol. 2009 Mar 1; 27(7):1047-53. Epub 2008 Dec 15.
    View PubMed
  94. Dronca RS, Loprinzi CL, Hartmann LC. Breast cancer risk reduction: SERMs, surgery, and beyond Menopausal Management. 2009 Mar/Apr; 18(2):14-22.
  95. Loprinzi CL, Dueck AC, Khoyratty BS, Barton DL, Jafar S, Rowland KM Jr, Atherton PJ, Marsa GW, Knutson WH, Bearden JD 3rd, Kottschade L, Fitch TR. A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). Ann Oncol. 2009 Mar; 20(3):542-9. Epub 2009 Jan 06.
    View PubMed
  96. Zou H, Taylor WR, Harrington JJ, Hussain FT, Cao X, Loprinzi CL, Levine TR, Rex DK, Ahnen D, Knigge KL, Lance P, Jiang X, Smith DI, Ahlquist DA. High detection rates of colorectal neoplasia by stool DNA testing with a novel digital melt curve assay. Gastroenterology. 2009 Feb; 136(2):459-70. Epub 2008 Oct 15.
    View PubMed
  97. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Wolf S. Newer antidepressants for hot flashes--should their efficacy still be up for debate? Menopause. 2009 Jan-Feb; 16(1):184-7.
    View PubMed
  98. Mincey B, Dentchev T, Sloan J, Hines S, Perez E, Johnson D, Schaefer P, Alberts S, Liu H, Wender D, Mazurczak M, Nikcevich D, Loprinzi C. Immediate vs. Delayed Zoledronic Acid for Prevention of Bone Loss in Postmenopausal Women with Breast Cancer Starting Letrozole After Tamoxifen - N03CC. Breast Cancer Res Treat. 2009; 117:603-9.
    View PubMed
  99. Schnadig ID, Fromme EK, Loprinzi CL, Sloan JA, Mori M, Li H, Beer TM. Patient-physician disagreement regarding performance status is associated with worse survivorship in patients with advanced cancer. Cancer. 2008 Oct 15; 113(8):2205-14.
    View PubMed
  100. Ahlquist DA, Sargent DJ, Loprinzi CL, Levin TR, Rex DK, Ahnen DJ, Knigge K, Lance MP, Burgart LJ, Hamilton SR, Allison JE, Lawson MJ, Devens ME, Harrington JJ, Hillman SL. Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008 Oct 7; 149(7):441-50, W81.
    View PubMed
  101. Grothey A, Adjei AA, Alberts SR, Perez EA, Jaeckle KA, Loprinzi CL, Sargent DJ, Sloan JA, Buckner JC, North Central Cancer Treatment Group. North Central Cancer Treatment Group--achievements and perspectives. Semin Oncol. 2008 Oct; 35(5):530-44.
    View PubMed
  102. Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol. 2008 Oct; 9(10):993-1001.
    View PubMed
  103. Jatoi A, Rowland K, Sloan JA, Gross HM, Fishkin PA, Kahanic SP, Novotny PJ, Schaefer PL, Johnson DB, Tschetter LK, Loprinzi CL. Tetracycline to prevent epidermal growth factor receptor inhibitor-induced skin rashes: results of a placebo-controlled trial from the North Central Cancer Treatment Group (N03CB). Cancer. 2008 Aug 15; 113(4):847-53.
    View PubMed
  104. Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008 Jul; 44(11):1507-15. Epub 2008 Jun 18.
    View PubMed
  105. Loprinzi CL, Barton DL, Sloan JA, Novotny PJ, Dakhil SR, Verdirame JD, Knutson WH, Kelaghan J, Christensen B. Mayo Clinic and North Central Cancer Treatment Group hot flash studies: a 20-year experience. Menopause. 2008 Jul-Aug; 15(4 Pt 1):655-60.
    View PubMed
  106. Rao RD, Flynn PJ, Sloan JA, Wong GY, Novotny P, Johnson DB, Gross HM, Renno SI, Nashawaty M, Loprinzi CL. Efficacy of lamotrigine in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled trial, N01C3. Cancer. 2008 Jun 15; 112(12):2802-8.
    View PubMed
  107. Bleicher J, Bhaskara A, Huyck T, Constantino S, Bardia A, Loprinzi CL, Silberstein PT. Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials. J Support Oncol. 2008 Jan; 6(1):27-32.
    View PubMed
  108. Thompson S, Bardia A, Tan A, Barton DL, Kottschade L, Sloan JA, Christensen B, Smith D, Loprinzi CL. Levetiracetam for the treatment of hot flashes: a phase II study. Support Care Cancer. 2008 Jan; 16(1):75-82. Epub 2007 Jun 28.
    View PubMed
  109. Croghan G, Croghan I, Hurt R, Kaur J, Novotny P, Sloan J, DeKrey W, Steen P, Loprinzi C. A Comparison by Ethnicity of a 15 Mg/16 Hour Nicotine Patch Alone Versus Nicotine Nasal Spray Alone Verus Both. J Health Care for the Poor and Underserved. 2008.
    View PubMed
  110. Cheville A, Sloan J, Northfelt D, Jillella A, Wong G, Bearden J, Liu H, Schaefer P, Marchello B, Christensen B, Loprinzi C. The Efficacy of Lidocaine Patch in the Management of Postsurgical Neuropathic Pain in Patients with Cancer: A Phase III Double-Blind, Crossover Study (N01CB). J Pain Symp Manag. 2008.
    View PubMed
  111. Rao RD, Michalak JC, Sloan JA, Loprinzi CL, Soori GS, Nikcevich DA, Warner DO, Novotny P, Kutteh LA, Wong GY, North Central Cancer Treatment Group. Efficacy of gabapentin in the management of chemotherapy-induced peripheral neuropathy: a phase 3 randomized, double-blind, placebo-controlled, crossover trial (N00C3). Cancer. 2007 Nov 1; 110(9):2110-8.
    View PubMed
  112. Loprinzi CL, Maddocks-Christianson K, Wolf SL, Rao RD, Dyck PJ, Mantyh P, Dyck PJ. The Paclitaxel acute pain syndrome: sensitization of nociceptors as the putative mechanism. Cancer J. 2007 Nov-Dec; 13(6):399-403.
    View PubMed
  113. Clark MM, Vickers KS, Hathaway JC, Smith M, Looker SA, Petersen LR, Pinto BM, Rummans TA, Loprinzi CL. Physical activity in patients with advanced-stage cancer actively receiving chemotherapy. J Support Oncol. 2007 Nov-Dec; 5(10):487-93.
    View PubMed
  114. Jatoi A, Dakhil SR, Nguyen PL, Sloan JA, Kugler JW, Rowland KM Jr, Soori GS, Wender DB, Fitch TR, Novotny PJ, Loprinzi CL. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007 Sep 15; 110(6):1396-403.
    View PubMed
  115. Kottschade L, Loprinzi C, Rao R. Vitamin e for the prevention of chemotherapy-induced peripheral neuropathy: rationale for an ongoing clinical trial. Support Cancer Ther. 2007 Sep 1; 4(4):251-3.
    View PubMed
  116. Barton DL, Loprinzi CL, Atherton P, Raymond J, Shanafelt T, Hines S, Palmieri F, Rummans T, Adjei AA, Sloan J. Phase II Evaluation of Desipramine for the Treatment of Hot Flashes. Support Cancer Ther. 2007 Sep 1; 4(4):219-24.
    View PubMed
  117. Pruthi S, Thompson SL, Novotny PJ, Barton DL, Kottschade LA, Tan AD, Sloan JA, Loprinzi CL. Pilot evaluation of flaxseed for the management of hot flashes. J Soc Integr Oncol. 2007 Summer; 5(3):106-12.
    View PubMed
  118. Barton DL, Wender DB, Sloan JA, Dalton RJ, Balcueva EP, Atherton PJ, Bernath AM Jr, DeKrey WL, Larson T, Bearden JD 3rd, Carpenter PC, Loprinzi CL. Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. J Natl Cancer Inst. 2007 May 2; 99(9):672-9.
    View PubMed
  119. Perez DG, Zahasky KM, Loprinzi CL, Sloan J, Novotny P, Barton D, Pritchard KI. Tamoxifen-associated hot flashes in women. Support Cancer Ther. 2007 May 1; 4(3):152-6.
    View PubMed
  120. Halyard MY, Jatoi A, Sloan JA, Bearden JD 3rd, Vora SA, Atherton PJ, Perez EA, Soori G, Zalduendo AC, Zhu A, Stella PJ, Loprinzi CL. Does zinc sulfate prevent therapy-induced taste alterations in head and neck cancer patients? Results of phase III double-blind, placebo-controlled trial from the North Central Cancer Treatment Group (N01C4). Int J Radiat Oncol Biol Phys. 2007 Apr 1; 67(5):1318-22.
    View PubMed
  121. Loprinzi CL, Barton DL, Jatoi A, Sloan J, Martenson J, Steensma D, Rao R, Novotny P, Sood A, Grothey A, Minasian L, Windschitl H. Symptom control trials: a 20-year experience. J Support Oncol. 2007 Mar; 5(3):119-25, 128.
    View PubMed
  122. Sood A, Barton DL, Bauer BA, Loprinzi CL. A critical review of complementary therapies for cancer-related fatigue. Integr Cancer Ther. 2007 Mar; 6(1):8-13.
    View PubMed
  123. Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: An evidence-based review. Clin Ther. 2007 Feb; 29(2):230-41.
    View PubMed
  124. Croghan IT, Hurt RD, Dakhil SR, Croghan GA, Sloan JA, Novotny PJ, Rowland KM, Bernath A, Loots ML, Le-Lindqwister NA, Tschetter LK, Garneau SC, Flynn KA, Ebbert LP, Wender DB, Loprinzi CL. Randomized comparison of a nicotine inhaler and bupropion for smoking cessation and relapse prevention. Mayo Clin Proc. 2007 Feb; 82(2):186-95.
    View PubMed
  125. Loprinzi CL, Kugler JW, Barton DL, Dueck AC, Tschetter LK, Nelimark RA, Balcueva EP, Burger KN, Novotny PJ, Carlson MD, Duane SF, Corso SW, Johnson DB, Jaslowski AJ. Phase III trial of gabapentin alone or in conjunction with an antidepressant in the management of hot flashes in women who have inadequate control with an antidepressant alone: NCCTG N03C5. J Clin Oncol. 2007 Jan 20; 25(3):308-12. Epub 2006 Dec 04.
    View PubMed
  126. Vincent A, Barton DL, Mandrekar JN, Cha SS, Zais T, Wahner-Roedler DL, Keppler MA, Kreitzer MJ, Loprinzi C. Acupuncture for hot flashes: a randomized, sham-controlled clinical study. Menopause. 2007 Jan-Feb; 14(1):45-52.
    View PubMed
  127. Barton DL, Loprinzi C, Jatoi A, Vincent A, Limburg P, Bauer B, Sood A, Good M, Bearden JD 4th, Kelaghan J, Sloan J. Can complementary and alternative medicine clinical cancer research be successfully accomplished? The Mayo Clinic-North Central Cancer Treatment Group experience. J Soc Integr Oncol. 2006 Fall; 4(4):143-52.
    View PubMed
  128. Markovic SN, Suman VJ, Ingle JN, Kaur JS, Pitot HC, Loprinzi CL, Rao RD, Creagan ET, Pittelkow MR, Allred JB, Nevala WK, Celis E. Peptide vaccination of patients with metastatic melanoma: improved clinical outcome in patients demonstrating effective immunization. Am J Clin Oncol. 2006 Aug; 29(4):352-60.
    View PubMed
  129. Bardia A, Thompson S, Atherton PJ, Barton DL, Sloan JA, Kottschade LA, Christensen B, Collins M, Loprinzi CL. Pilot evaluation of aprepitant for the treatment of hot flashes. Support Cancer Ther. 2006 Jul 1; 3(4):240-6.
    View PubMed
  130. Clark MM, Hurt RD, Croghan IT, Patten CA, Novotny P, Sloan JA, Dakhil SR, Croghan GA, Wos EJ, Rowland KM, Bernath A, Morton RF, Thomas SP, Tschetter LK, Garneau S, Stella PJ, Ebbert LP, Wender DB, Loprinzi CL. The prevalence of weight concerns in a smoking abstinence clinical trial. Addict Behav. 2006 Jul; 31(7):1144-52. Epub 2005 Aug 30.
    View PubMed
  131. Alberts SR, Novotny PJ, Sloan JA, Danella J, Bostwick DG, Sebo TJ, Blute ML, Fitch TR, Levitt R, Lieberman R, Loprinzi CL. Flutamide in men with prostatic intraepithelial neoplasia: a randomized, placebo-controlled chemoprevention trial. Am J Ther. 2006 Jul-Aug; 13(4):291-7.
    View PubMed
  132. Pockaj BA, Gallagher JG, Loprinzi CL, Stella PJ, Barton DL, Sloan JA, Lavasseur BI, Rao RM, Fitch TR, Rowland KM, Novotny PJ, Flynn PJ, Richelson E, Fauq AH. Phase III double-blind, randomized, placebo-controlled crossover trial of black cohosh in the management of hot flashes: NCCTG Trial N01CC1. J Clin Oncol. 2006 Jun 20; 24(18):2836-41.
    View PubMed
  133. Perez DG, Loprinzi CL, Sloan J, Novotny P, Barton D, Carpenter L, Smith D, Christensen B, Rummans T. Pilot evaluation of bupropion for the treatment of hot flashes. J Palliat Med. 2006 Jun; 9(3):631-7.
    View PubMed
  134. Sideras K, Schaefer PL, Okuno SH, Sloan JA, Kutteh L, Fitch TR, Dakhil SR, Levitt R, Alberts SR, Morton RF, Rowland KM, Novotny PJ, Loprinzi CL. Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. Mayo Clin Proc. 2006 Jun; 81(6):758-67.
    View PubMed
  135. Loprinzi CL, Levitt R, Barton D, Sloan JA, Dakhil SR, Nikcevich DA, Bearden JD 3rd, Mailliard JA, Tschetter LK, Fitch TR, Kugler JW. Phase III comparison of depomedroxyprogesterone acetate to venlafaxine for managing hot flashes: North Central Cancer Treatment Group Trial N99C7. J Clin Oncol. 2006 Mar 20; 24(9):1409-14. Epub 2006 Feb 27.
    View PubMed
  136. Steensma DP, Molina R, Sloan JA, Nikcevich DA, Schaefer PL, Rowland KM Jr, Dentchev T, Novotny PJ, Tschetter LK, Alberts SR, Hogan TF, Law A, Loprinzi CL. Phase III study of two different dosing schedules of erythropoietin in anemic patients with cancer. J Clin Oncol. 2006 Mar 1; 24(7):1079-89.
    View PubMed
  137. Carlson RW, Brown E, Burstein HJ, Gradishar WJ, Hudis CA, Loprinzi C, Mamounas EP, Perez EA, Pritchard K, Ravdin P, Recht A, Somlo G, Theriault RL, Winer EP, Wolff AC, National Comprehensive Cancer Network. NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw. 2006 Mar; 4 Suppl 1:S1-26.
    View PubMed
  138. Barton DL, Loprinzi C, Atherton PJ, Kottschade L, Collins M, Carpenter P, Adjei A, Rummans TA, Shanafelt T, Christensen B, Sloan J. Dehydroepiandrosterone for the treatment of hot flashes: a pilot study. Support Cancer Ther. 2006 Jan 1; 3(2):91-7.
    View PubMed
  139. Sood A, Barton DL, Loprinzi CL. Use of methylphenidate in patients with cancer. Am J Hosp Palliat Care. 2006 Jan-Feb; 23(1):35-40.
    View PubMed
  140. Loprinzi CL. Antidepressants and gabapentin. Menopause Management. 2006; 15(suppl 1):29-32.
  141. Loprinzi CL, Stearns V, Barton D. Centrally active nonhormonal hot flash therapies. Am J Med. 2005 Dec 19; 118 Suppl 12B:118-23.
    View PubMed
  142. Perez EA, Suman VJ, Rowland KM, Ingle JN, Salim M, Loprinzi CL, Flynn PJ, Mailliard JA, Kardinal CG, Krook JE, Thrower AR, Visscher DW, Jenkins RB. Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252. Clin Breast Cancer. 2005 Dec; 6(5):425-32.
    View PubMed
  143. Desch CE, Benson AB, Somerfield MR, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Pfister DG, Virgo KS, Petrelli NJ. Colorectal cancer surveillance: 2005 update of an American Society of Clinical Oncology Practice Guideline. J Clin Oncol. 2005 Nov 20; 23(33):8512-19.
    View PubMed
  144. Loprinzi CL, Flynn PJ, Carpenter LA, Atherton P, Barton DL, Shanafelt TD, Rummans TA, Sloan JA, Adjei AA, Mincey BA, Fitch TR, Collins M. Pilot evaluation of citalopram for the treatment of hot flashes in women with inadequate benefit from venlafaxine. J Palliat Med. 2005 Oct; 8(5):924-30.
    View PubMed
  145. Perez DG, Loprinzi CL. Newer antidepressants and other nonhormonal agents for the treatment of hot flashes. Compr Ther. 2005 Fall; 31(3):224-36.
    View PubMed
  146. Loprinzi CL, Levitt R, Barton DL, Sloan JA, Atherton PJ, Smith DJ, Dakhil SR, Moore DF Jr, Krook JE, Rowland KM Jr, Mazurczak MA, Berg AR, Kim GP, North Central Cancer Treatment Group. Evaluation of shark cartilage in patients with advanced cancer: a North Central Cancer Treatment Group trial. Cancer. 2005 Jul 1; 104(1):176-82.
    View PubMed
  147. Vickers KS, Hathaway JC, Patten CA, Clark MM, Britt TL, Looker SA, Johnson PT, Loprinzi CL. Cancer patients' and patient advocates' perspectives on a novel information source: a qualitative study of the art of oncology, when the tumor is not the target. J Clin Oncol. 2005 Jun 20; 23(18):4013-20.
    View PubMed
  148. Ryan M, Moynihan TJ, Loprinzi CL. As-needed morphine: yes, but at what dose and at what interval? J Clin Oncol. 2005 Jun 1; 23(16):3849-52.
    View PubMed
  149. Adelson KB, Loprinzi CL, Hershman DL. Treatment of hot flushes in breast and prostate cancer. Expert Opin Pharmacother. 2005 Jun; 6(7):1095-106.
    View PubMed
  150. Witzig TE, Silberstein PT, Loprinzi CL, Sloan JA, Novotny PJ, Mailliard JA, Rowland KM, Alberts SR, Krook JE, Levitt R, Morton RF. Phase III, randomized, double-blind study of epoetin alfa compared with placebo in anemic patients receiving chemotherapy. J Clin Oncol. 2005 Apr 20; 23(12):2606-17. Epub 2004 Sep 27.
    View PubMed
  151. Loprinzi CL, Moynihan TJ. Mastering the art of oncology. Minn Med. 2005 Apr; 88(4):34-5, 54.
    View PubMed
  152. Whelan TJ, Loprinzi C. Physician/patient decision aids for adjuvant therapy. J Clin Oncol. 2005 Mar 10; 23(8):1627-30.
    View PubMed
  153. Hoda D, Jatoi A, Burnes J, Loprinzi C, Kelly D. Should patients with advanced, incurable cancers ever be sent home with total parenteral nutrition? A single institution's is 20-year experience. Cancer. 2005 Feb 15; 103(4):863-8.
    View PubMed
  154. Molina JR, Barton DL, Loprinzi CL. Chemotherapy-induced ovarian failure: manifestations and management. Drug Saf. 2005; 28(5):401-16.
    View PubMed
  155. Loprinzi CL, Moynihan TJ. Discussing your chemotherapy treatment options with your doctor. Coping. 2005:20-3.
    View PubMed
  156. Okuno S, Foote R, Olmscheid M, Sloan J, Sapiente R, Novotny P, Anthes M, Loprinzi C An Evaluation of an Oral Capsaicin Lozenge for Preventing Radiation-Induced Mucoxtitis J of Cancer Integrative Medicine. 2005; 2:179-183.
    View PubMed
  157. Jatoi A, Jett JR, Sloan J, Novotny P, Ford J, Prabhakar U, Loprinzi CL. A pilot study on safety and pharmacokinetics of infliximab for the cancer anorexia/weight loss syndrome in non-small-cell lung cancer patients. Support Care Cancer. 2004 Dec; 12(12):859-63. Epub 2004 Sep 15.
    View PubMed
  158. Loprinzi CL, Barton DL, Carpenter LA, Sloan JA, Novotny PJ, Gettman MT, Christensen BJ. Pilot evaluation of paroxetine for treating hot flashes in men. Mayo Clin Proc. 2004 Oct; 79(10):1247-51.
    View PubMed
  159. Jatoi A, Egner J, Loprinzi CL, Sloan JA, Novotny PJ, Dakhil SR, Mailliard JA, Klee GG, Krook JE. Investigating the utility of serum cytokine measurements in a multi-institutional cancer anorexia/weight loss trial. Support Care Cancer. 2004 Sep; 12(9):640-4.
    View PubMed
  160. Jatoi A, Rowland K, Loprinzi CL, Sloan JA, Dakhil SR, MacDonald N, Gagnon B, Novotny PJ, Mailliard JA, Bushey TI, Nair S, Christensen B, North Central Cancer Treatment Group. An eicosapentaenoic acid supplement versus megestrol acetate versus both for patients with cancer-associated wasting: a North Central Cancer Treatment Group and National Cancer Institute of Canada collaborative effort. J Clin Oncol. 2004 Jun 15; 22(12):2469-76.
    View PubMed
  161. Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol. 2004 May 15; 22(10):1797-806. Epub 2004 Apr 05.
    View PubMed
  162. Shanafelt TD, Loprinzi C, Marks R, Novotny P, Sloan J. Are chemotherapy response rates related to treatment-induced survival prolongations in patients with advanced cancer? J Clin Oncol. 2004 May 15; 22(10):1966-74.
    View PubMed
  163. Barton D, Wilwerding M, Carpenter L, Loprinzi C. Libido as part of sexuality in female cancer survivors. Oncol Nurs Forum. 2004 May; 31(3):599-609.
    View PubMed
  164. Perez DG, Loprinzi CL, Barton DL, Pockaj BA, Sloan J, Novotny PJ, Christensen BJ. Pilot evaluation of mirtazapine for the treatment of hot flashes. J Support Oncol. 2004 Jan-Feb; 2(1):50-6.
    View PubMed
  165. Witzig T, Silberstein P, Loprinzi C, Sloan J, Novotny P, Mailliard J, Rowland K, Alberts S, Nikcevich D, Levitt R, Morton R A Phase III Randomized Double-Blind Study of Epoetin alfa Versus Placebo in Anemic Patients with Cancer Undergoing Chemotherapy J Clin Oncol. 2004; 22:1-12.
    View PubMed
  166. Barton D, Loprinzi C. Making sense of the evidence regarding nonhormonal treatments for hot flashes. Clin J Oncol Nurs. 2004; 8(1):39-42.
    View PubMed
  167. Okuno SH, Foote RL, Olmscheid MA, Sloan JA, Sapiente RA, Novotny PJ, Anthes ML, Loprinzi CL. Evaluation of an oral capsaicin lozenge for preventing radiation-induced mucositis. Journal of Cancer Integrative Medicine. 2004; 2(4):179-83.
    View PubMed
  168. Pockaj BA, Loprinzi CL, Sloan JA, Novotny PJ, Barton DL, Hagenmaier A, Zhang H, Lambert GH, Reeser KA, Wisbey JA. Pilot evaluation of black cohosh for the treatment of hot flashes in women. Cancer Invest. 2004; 22(4):515-21.
    View PubMed
  169. Jacobson SD, Loprinzi CL, Sloan JA, Wilke JL, Novotny PJ, Okuno SH, Jatoi A, Moynihan TJ. Glutamine does not prevent paclitaxel-associated myalgias and arthralgias. J Support Oncol. 2003 Nov-Dec; 1(4):274-8.
    View PubMed
  170. Hoda D, Perez DG, Loprinzi CL. Hot flashes in breast cancer survivors. Breast J. 2003 Sep-Oct; 9(5):431-8.
    View PubMed
  171. Jatoi A, Suman VJ, Schaefer P, Block M, Loprinzi C, Roche P, Garneau S, Morton R, Stella PJ, Alberts SR, Pittelkow M, Sloan J, Pagano R. A phase II study of topical ceramides for cutaneous breast cancer. Breast Cancer Res Treat. 2003 Jul; 80(1):99-104.
    View PubMed
  172. Loprinzi C, Rajkumar SV. Why not start with thalidomide? J Clin Oncol. 2003 Jun 1; 21(11):2211-4.
    View PubMed
  173. Loprinzi CL, Hayes D, Smith T. Doc, shouldn't we be getting some tests? J Clin Oncol. 2003 May 1; 21(9 Suppl):108s-111s.
    View PubMed
  174. Loprinzi CL, Johnson ME, Steer G. Doc, how much time do I have? J Clin Oncol. 2003 May 1; 21(9 Suppl):5s-7s.
    View PubMed
  175. Barton DL, Loprinzi CL, Novotny P, Shanafelt T, Sloan J, Wahner-Roedler D, Rummans TA, Christensen B, Dakhill SR, Martin LS. Pilot evaluation of citalopram for the relief of hot flashes. J Support Oncol. 2003 May-Jun; 1(1):47-51.
    View PubMed
  176. Croghan GA, Sloan JA, Croghan IT, Novotny P, Hurt RD, DeKrey WL, Mailliard JA, Ebbert LP, Swan DK, Walsh DJ, Wiesenfeld M, Levitt R, Stella P, Johnson PA, Tschetter LK, Loprinzi C. Comparison of nicotine patch alone versus nicotine nasal spray alone versus a combination for treating smokers: a minimal intervention, randomized multicenter trial in a nonspecialized setting. Nicotine Tob Res. 2003 Apr; 5(2):181-7.
    View PubMed
  177. Loprinzi CL, Ravdin PM. Decision-making for patients with resectable breast cancer: individualized decisions for and by patients and their physicians. J Natl Compr Canc Netw. 2003 Apr; 1(2):189-96.
    View PubMed
  178. Sandler RS, Halabi S, Baron JA, Budinger S, Paskett E, Keresztes R, Petrelli N, Pipas JM, Karp DD, Loprinzi CL, Steinbach G, Schilsky R. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003 Mar 6; 348(10):883-90.
    View PubMed
  179. Hurt RD, Krook JE, Croghan IT, Loprinzi CL, Sloan JA, Novotny PJ, Kardinal CG, Knost JA, Tirona MT, Addo F, Morton RF, Michalak JC, Schaefer PL, Porter PA, Stella PJ. Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking. J Clin Oncol. 2003 Mar 1; 21(5):914-20.
    View PubMed
  180. Witizig T, T S, Loprinzi C, Sloan J, Novotny P, Mailliard J, Rowland K, Levitt R, Morton R A Phase III Randomized Double-Blind Study of Epoetin alfa Versus Placebo in Anemic Patients With Cancer Undergoing Chemotherapy J of Clin Oncol. 2003.
    View PubMed
  181. Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist. 2003; 8(5):474-87.
    View PubMed
  182. Barton DL, Loprinzi CL, Gostout B. Management of menopausal symptoms in cancer patients. Menopause Digest. 2003; 15(2):26-7.
  183. Jatoi A, Loprinzi CL. The cancer anorexia/weight loss syndrome-a review of therapeutic strategies. Business Briefing:European PharmacoTherapy. 2003;102-4.
  184. Sloan JA, Vargas-Chanes D, Kamath CC, Sargent DJ, Novotny P, Atherton P, Allmer C, Fridley BL, Frost M, Loprinzi CL. Detecting worms, ducks, and elephants: A simple approach for defining clinically relevant effects in quality-of-life measures. Journal of Cancer Integrative Medicine. 2003; 1(1):41-7.
    View PubMed
  185. Stearns V, Loprinzi CL. New therapeutic approaches for hot flashes. Journal of Supportive Oncology. 2003; 1(1):11-21.
    View PubMed
  186. Barton D, Loprinzi C. Novel approaches to preventing chemotherapy-induced cognitive dysfunction in breast cancer: the art of the possible. Clinical Breast Cancer. 2002 Dec; 3 Suppl 3:S121-7.
    View PubMed
  187. Barton D, Loprinzi C, Quella S, Sloan J, Pruthi S, Novotny P. Depomedroxyprogesterone acetate for hot flashes. J Pain Symptom Manage. 2002 Dec; 24(6):603-7.
    View PubMed
  188. Loprinzi L, Barton DL, Sloan JA, Zahasky KM, Smith DA, Pruthi S, Novotny PJ, Perez EA, Christensen BJ. Pilot evaluation of gabapentin for treating hot flashes. Mayo Clin Proc. 2002 Nov; 77(11):1159-63.
    View PubMed
  189. Shanafelt TD, Barton DL, Adjei AA, Loprinzi CL. Pathophysiology and treatment of hot flashes. Mayo Clin Proc. 2002 Nov; 77(11):1207-18.
    View PubMed
  190. Thome SD, Loprinzi CL, Heldebrant MP. Determination of potential adjuvant systemic therapy benefits for patients with resected cutaneous melanomas. Mayo Clin Proc. 2002 Sep; 77(9):913-7.
    View PubMed
  191. Hammack JE, Michalak JC, Loprinzi CL, Sloan JA, Novotny PJ, Soori GS, Tirona MT, Rowland KM Jr, Stella PJ, Johnson JA. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain. 2002 Jul; 98(1-2):195-203.
    View PubMed
  192. Loprinzi CL, Barton DL, Rhodes DJ, Wahner-Roedler DL. Newer antidepressants for hot flashes. Patient Care. 2002 Jul; 36(9):45-6, 49-51.
    View PubMed
  193. Sloan JA, Goldberg RM, Sargent DJ, Vargas-Chanes D, Nair S, Cha SS, Novotny PJ, Poon MA, O'Connell MJ, Loprinzi CL. Women experience greater toxicity with fluorouracil-based chemotherapy for colorectal cancer. J Clin Oncol. 2002 Mar 15; 20(6):1491-8.
    View PubMed
  194. Loprinzi CL, Sloan JA, Perez EA, Quella SK, Stella PJ, Mailliard JA, Halyard MY, Pruthi S, Novotny PJ, Rummans TA. Phase III evaluation of fluoxetine for treatment of hot flashes. J Clin Oncol. 2002 Mar 15; 20(6):1578-83.
    View PubMed
  195. Jatoi A, Windschitl HE, Loprinzi CL, Sloan JA, Dakhil SR, Mailliard JA, Pundaleeka S, Kardinal CG, Fitch TR, Krook JE, Novotny PJ, Christensen B. Dronabinol versus megestrol acetate versus combination therapy for cancer-associated anorexia: a North Central Cancer Treatment Group study. J Clin Oncol. 2002 Jan 15; 20(2):567-73.
    View PubMed
  196. Barton DL, Loprinzi C, Gostout B. Current management of menopausal symptoms in cancer patients. Oncology (Williston Park) 2002 Jan; 16(1):67-72, 74; discussion 75-6, 79-80.
    View PubMed
  197. Jatoi A, Yamashita J, Sloan JA, Novotny PJ, Windschitl HE, Loprinzi CL. Does megestrol acetate down-regulate interleukin-6 in patients with cancer-associated anorexia and weight loss? A North Central Cancer Treatment Group investigation. Support Care Cancer. 2002 Jan; 10(1):71-5.
    View PubMed
  198. Barton D, La Vasseur B, Loprinzi C, Novotny P, Wilwerding MB, Sloan J. Venlafaxine for the control of hot flashes: results of a longitudinal continuation study. Oncol Nurs Forum. 2002 Jan-Feb; 29(1):33-40.
    View PubMed
  199. Barton DL, Loprinzi CL, Ko MG. Managing hot flashes: The truth about the alternatives to traditional hormone replacement therapy. Menopause Manage. 2002;11(3):15-19.
  200. Sloan JA, Loprinzi CL, Novotny PJ, Barton DL, Lavasseur BI, Windschitl H. Methodologic lessons learned from hot flash studies. J Clin Oncol. 2001 Dec 1; 19(23):4280-90.
    View PubMed
  201. Loprinzi CL, Barton DL, Rhodes DJ, Wahner-Roedler DL. Newer antidepressants for hot flashes. Contemp Ob Gyn. 2001 Nov; 46(11):61-2, 64, 67 passim.
  202. Messina MJ, Loprinzi CL. Soy for breast cancer survivors: a critical review of the literature. J Nutr. 2001 Nov; 131(11 Suppl):3095S-108S.
    View PubMed
  203. Jatoi A, Loprinzi CL, Sloan JA, Klee GG, Windschitl HE. Neuropeptide Y, leptin, and cholecystokinin 8 in patients with advanced cancer and anorexia: a North Central Cancer Treatment Group exploratory investigation. Cancer. 2001 Aug 1; 92(3):629-33.
    View PubMed
  204. Sloan JA, Loprinzi CL, Laurine JA, Novotny PJ, Vargas-Chanes D, Krook JE, O'Connell MJ, Kugler JW, Tirona MT, Kardinal CG, Wiesenfeld M, Tschetter LK, Hatfield AK, Schaefer PL. A simple stratification factor prognostic for survival in advanced cancer: the good/bad/uncertain index. J Clin Oncol. 2001 Aug 1; 19(15):3539-46.
    View PubMed
  205. Jatoi A, Loprinzi CL. An update: cancer-associated anorexia as a treatment target. Curr Opin Clin Nutr Metab Care. 2001 May; 4(3):179-82.
    View PubMed
  206. Loprinzi CL, Barton DL, Rhodes D. Management of hot flashes in breast-cancer survivors. Lancet Oncol. 2001 Apr; 2(4):199-204.
    View PubMed
  207. Jatoi A Jr, Loprinzi CL. Current management of cancer-associated anorexia and weight loss. Oncology (Williston Park) 2001 Apr; 15(4):497-502, 508; discussion 508-10.
    View PubMed
  208. Loprinzi CL, Thome SD. Understanding the utility of adjuvant systemic therapy for primary breast cancer. J Clin Oncol. 2001 Feb 15; 19(4):972-9.
    View PubMed
  209. Barton D, Loprinzi C, Wahner-Roedler D. Hot flashes: aetiology and management. Drugs Aging. 2001; 18(8):597-606.
    View PubMed
  210. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh S, Pfeifle DM, Wender DB, Burch OA. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. J Clin Oncol (Classic Papers and Current Comments) 2001; 92(3):139-43.
  211. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, LaVasseur BI, Barton DL, Novotny PJ, Dakhil SR, Rodger K, Rummans TA, Christensen BJ. Venlafaxine in management of hot flashes in survivors of breast cancer: a randomised controlled trial. Lancet. 2000 Dec 16; 356(9247):2059-63.
    View PubMed
  212. Benson AB 3rd, Desch CE, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Smith TJ, Somerfield MR. 2000 update of American Society of Clinical Oncology colorectal cancer surveillance guidelines. J Clin Oncol. 2000 Oct 15; 18(20):3586-8.
    View PubMed
  213. Loprinzi CL, Hayes D, Smith T. Doc, shouldn't we be getting some tests? J Clin Oncol. 2000 Jun; 18(11):2345-8.
    View PubMed
  214. Sloan JA, Novotny PJ, Loprinzi CL. Design and analysis of cancer control studies using the SAS system. SUGI 25 Proceedings. 2000 Apr 9-12:259-25.
  215. Loprinzi CL, Zahasky KM, Sloan JA, Novotny PJ, Quella SK. Tamoxifen-induced hot flashes. Clin Breast Cancer. 2000 Apr; 1(1):52-6.
    View PubMed
  216. Quella SK, Loprinzi CL, Barton DL, Knost JA, Sloan JA, LaVasseur BI, Swan D, Krupp KR, Miller KD, Novotny PJ. Evaluation of soy phytoestrogens for the treatment of hot flashes in breast cancer survivors: A North Central Cancer Treatment Group Trial. J Clin Oncol. 2000 Mar; 18(5):1068-74.
    View PubMed
  217. Loprinzi CL, Alberts SR, Christensen BJ, Hanson LJ, Farley DR, Broers JK, Betcher DL, Grady RE, Southorn PA, Johnson TM, Perez EA. History of the development of antiemetic guidelines at Mayo Clinic Rochester. Mayo Clin Proc. 2000 Mar; 75(3):303-9.
    View PubMed
  218. Loprinzi CL, Johnson ME, Steer G. Doc, how much time do I have? J Clin Oncol. 2000 Feb; 18(3):699-701.
    View PubMed
  219. Sloan JA, Loprinzi CL, Novotny PJ, Okuno S, Nair S, Barton DL. Sex differences in fluorouracil-induced stomatitis. J Clin Oncol. 2000 Jan; 18(2):412-20.
    View PubMed
  220. Sloan J, Loprinzi C, Novotny P, Okuno S, Barton D, Nair S Gender differences in 5FU-induced stomatitis J Clin Oncol. 2000; 18(2):412-420.
    View PubMed
  221. Jatoi A, Loprinzi CL. Nutritional determinants of survival among patients with breast cancer. Surg Clin North Am. 1999 Oct; 79(5):1145-56.
    View PubMed
  222. Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM Jr, Camoriano JK, Novotny PJ, Christensen BJ. Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol. 1999 Oct; 17(10):3299-306.
    View PubMed
  223. Ingle JN, Suman VJ, Johnson PA, Krook JE, Mailliard JA, Wheeler RH, Loprinzi CL, Perez EA, Jordan VC, Dowsett M. Evaluation of tamoxifen plus letrozole with assessment of pharmacokinetic interaction in postmenopausal women with metastatic breast cancer. Clin Cancer Res. 1999 Jul; 5(7):1642-9.
    View PubMed
  224. Bretscher M, Rummans T, Sloan J, Kaur J, Bartlett A, Borkenhagen L, Loprinzi C. Quality of life in hospice patients. A pilot study. Psychosomatics. 1999 Jul-Aug; 40(4):309-13.
    View PubMed
  225. Quella SK, Loprinzi CL, Sloan J, Novotny P, Perez EA, Burch PA, Antolak SJ Jr, Pisansky TM. Pilot evaluation of venlafaxine for the treatment of hot flashes in men undergoing androgen ablation therapy for prostate cancer. J Urol. 1999 Jul; 162(1):98-102.
    View PubMed
  226. Okuno SH, Woodhouse CO, Loprinzi CL, Sloan JA, LaVasseur BI, Clemens-Schutjer D, Swan D, Axvig C, Ebbert LP, Tirona MR, Michalak JC, Pierson N. Phase III controlled evaluation of glutamine for decreasing stomatitis in patients receiving fluorouracil (5-FU)-based chemotherapy. Am J Clin Oncol. 1999 Jun; 22(3):258-61.
    View PubMed
  227. Desch CE, Benson AB 3rd, Smith TJ, Flynn PJ, Krause C, Loprinzi CL, Minsky BD, Petrelli NJ, Pfister DG, Somerfield MR. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology. J Clin Oncol. 1999 Apr; 17(4):1312.
    View PubMed
  228. Ingle JN, Suman VJ, Kardinal CG, Krook JE, Mailliard JA, Veeder MH, Loprinzi CL, Dalton RJ, Hartmann LC, Conover CA, Pollak MN. A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic breast carcinoma. Cancer. 1999 Mar 15; 85(6):1284-92.
    View PubMed
  229. Peethambaram PP, Ingle JN, Suman VJ, Hartmann LC, Loprinzi CL. Randomized trial of diethylstilbestrol vs. tamoxifen in postmenopausal women with metastatic breast cancer. An updated analysis. Breast Cancer Res Treat. 1999 Mar; 54(2):117-22.
    View PubMed
  230. Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999 Feb 4; 340(5):346-50.
    View PubMed
  231. Loprinzi CL, Johnston PB, Sloan JA, Novotny P, Ellison N. Have medical oncologists recently modified surveillance testing patterns for melanoma and/or breast cancer survivors? Cancer Research, Therapy & Control. 1999; 9(3-4):205-14.
  232. Goldberg RM, Loprinzi CL. Cancer anorexia/cachexia. Cancer Treat Res. 1999; 100:31-41.
    View PubMed
  233. Okuno SH, Kozelsky T, Loprinzi CL, Nair S. Alleviation of gastrointestinal mucosal toxicity related to chemotherapy and radiation therapy: the NCCTG experience. Cancer Research, Therapy & Control. 1999; 9(3-4):193-6.
  234. Loprinzi CL. A flash on hot flashes. J Clin Oncol (Classic Papers and Current Comments) 1999; 4(2):348-9.
  235. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol (Classic Papers and Current Comments) 1999; 4(2):328-32.
  236. Loprinzi CL, Kuross SA, O'Fallon JR, Gesme DH, Gerstner JB, Rospond RM, Cobau CD, Goldberg RM. Randomized, placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol (Classic Papers and Current Comments) 1999; 3(2):514-9.
  237. Finck G, Barton DL, Loprinzi CL, Quella SK, Sloan JA. Definitions of hot flashes in breast cancer survivors. J Pain Symptom Manage. 1998 Nov; 16(5):327-33.
    View PubMed
  238. Sloan JA, Loprinzi CL, Kuross SA, Miser AW, O'Fallon JR, Mahoney MR, Heid IM, Bretscher ME, Vaught NL. Randomized comparison of four tools measuring overall quality of life in patients with advanced cancer. J Clin Oncol. 1998 Nov; 16(11):3662-73.
    View PubMed
  239. Loprinzi CL, Pisansky TM, Fonseca R, Sloan JA, Zahasky KM, Quella SK, Novotny PJ, Rummans TA, Dumesic DA, Perez EA. Pilot evaluation of venlafaxine hydrochloride for the therapy of hot flashes in cancer survivors. J Clin Oncol. 1998 Jul; 16(7):2377-81.
    View PubMed
  240. Quella SK, Loprinzi CL, Sloan JA, Vaught NL, DeKrey WL, Fischer T, Finck G, Pierson N, Pisansky T. Long term use of megestrol acetate by cancer survivors for the treatment of hot flashes. Cancer. 1998 May 1; 82(9):1784-8.
    View PubMed
  241. Barton DL, Loprinzi CL, Quella SK, Sloan JA, Veeder MH, Egner JR, Fidler P, Stella PJ, Swan DK, Vaught NL, Novotny P. Prospective evaluation of vitamin E for hot flashes in breast cancer survivors. J Clin Oncol. 1998 Feb; 16(2):495-500.
    View PubMed
  242. Sloan JA, Novotny PJ, Loprinzi CL. Analyzing quality of life data via the SAS system. SUGI. 1998; 23:1213-22.
  243. Sloan JA, Novotny PJ, Loprinzi CL. Analyzing Quality of Life (QOL) Endpoints in Clinical Trials via the SAS System. Statistics Data Analysis, and Modeling. 1998:1213-1222.
  244. Pritchard K, Loprinzi CL. Estrogen/hormone replacement therapy (ERT/HRT) in women with a previous diagnosis of breast cancer: is it safe and are there alternatives? ASCO Fall Educational Book. 1998:81-6.
  245. Perez EA, Loprinzi CL, Sloan JA, Owens DT, Novotny PJ, Bonner JA. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma. Cancer. 1997 Aug 15; 80(4):676-80.
    View PubMed
  246. Ellison N, Loprinzi CL, Kugler J, Hatfield AK, Miser A, Sloan JA, Wender DB, Rowland KM, Molina R, Cascino TL, Vukov AM, Dhaliwal HS, Ghosh C. Phase III placebo-controlled trial of capsaicin cream in the management of surgical neuropathic pain in cancer patients. J Clin Oncol. 1997 Aug; 15(8):2974-80.
    View PubMed
  247. Ingle JN, Johnson PA, Suman VJ, Gerstner JB, Mailliard JA, Camoriano JK, Gesme DH Jr, Loprinzi CL, Hatfield AK, Hartmann LC. A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinoma. Cancer. 1997 Jul 15; 80(2):218-24.
    View PubMed
  248. Peethambaram P, Weiss M, Loprinzi CL, Novotny P, O'Fallon JR, Erlichman C, O'Connell MJ, Laurie JA. An evaluation of postoperative follow-up tests in colon cancer patients treated for cure. Oncology. 1997 Jul-Aug; 54(4):287-92.
    View PubMed
  249. Okuno SH, Foote RL, Loprinzi CL, Gulavita S, Sloan JA, Earle J, Novotny PJ, Burk M, Frank AR. A randomized trial of a nonabsorbable antibiotic lozenge given to alleviate radiation-induced mucositis. Cancer. 1997 Jun 1; 79(11):2193-9.
    View PubMed
  250. Loprinzi CL, Abu-Ghazaleh S, Sloan JA, vanHaelst-Pisani C, Hammer AM, Rowland KM Jr, Law M, Windschitl HE, Kaur JS, Ellison N. Phase III randomized double-blind study to evaluate the efficacy of a polycarbophil-based vaginal moisturizer in women with breast cancer. J Clin Oncol. 1997 Mar; 15(3):969-73.
    View PubMed
  251. Loprinzi CL, Ghosh C, Camoriano J, Sloan J, Steen PD, Michalak JC, Schaefer PL, Novotny PJ, Gerstner JB, White DF, Hatfield AK, Quella SK. Phase III controlled evaluation of sucralfate to alleviate stomatitis in patients receiving fluorouracil-based chemotherapy. J Clin Oncol. 1997 Mar; 15(3):1235-8.
    View PubMed
  252. McGinnis WL, Loprinzi CL, Buskirk SJ, Sloan JA, Drummond RG, Frank AR, Shanahan TG, Kahanic SP, Moore RL, Schild SE, Humphrey SL. Placebo-controlled trial of sucralfate for inhibiting radiation-induced esophagitis. J Clin Oncol. 1997 Mar; 15(3):1239-43.
    View PubMed
  253. Chong SF, Bretscher ME, Mailliard JA, Tschetter LK, Kimmel DW, Hatfield AK, Loprinzi CL. Pilot study evaluating local anesthetics administered systemically for treatment of pain in patients with advanced cancer. J Pain Symptom Manage. 1997 Feb; 13(2):112-7.
    View PubMed
  254. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, Wender DB, Burch PA. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small cell lung cancer. J Clin Oncol (Classic Papers and Current Comments) 1997; 2(1):253-7.
  255. Sloan J, Novotny P, Loprinzi C, Nair S Graphical and analytical tools for the analysis of two-period crossover clinical trials SAS Users Group International (SUGI) Conference Proceedings. 1997; 22:1312-1317.
    View PubMed
  256. Hammack JE, Mailliard JA, Loprinzi CL, Rospond RM, O'Fallon JR, Wilwerding MB, Reuter NF, Michalak JC, Fidler P, Miser AW. Transdermal fentanyl in the management of cancer pain in ambulatory patients: an open-label pilot study. J Pain Symptom Manage. 1996 Oct; 12(4):234-40.
    View PubMed
  257. Williams MS, Burk M, Loprinzi CL, Hill M, Schomberg PJ, Nearhood K, O'Fallon JR, Laurie JA, Shanahan TG, Moore RL, Urias RE, Kuske RR, Engel RE, Eggleston WD. Phase III double-blind evaluation of an aloe vera gel as a prophylactic agent for radiation-induced skin toxicity. Int J Radiat Oncol Biol Phys. 1996 Sep 1; 36(2):345-9.
    View PubMed
  258. Pisansky TM, Loprinzi CL, Cha SS, Fitzgibbons RJ Jr, Grant CS, Hass AC, Reuter NF, Wold LE, Ingle JN, Kardinal CG. A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced breast carcinoma. Cancer. 1996 Jun 15; 77(12):2520-8.
    View PubMed
  259. Loprinzi CL, Okuno Sh, Pisansky TM, Sterioff S, Gaffey TA, Morton RF. Postsurgical changes of the breast that mimic inflammatory breast carcinoma. Mayo Clin Proc. 1996 Jun; 71(6):552-5.
    View PubMed
  260. Loprinzi CL, Messing EM, O'Fallon JR, Poon MA, Love RR, Quella SK, Trump DL, Morton RF, Novotny P. Toxicity evaluation of difluoromethylornithine: doses for chemoprevention trials. Cancer Epidemiol Biomarkers Prev. 1996 May; 5(5):371-4.
    View PubMed
  261. Loprinzi CL, Athmann LM, Kardinal CG, O'Fallon JR, See JA, Bruce BK, Dose AM, Miser AW, Kern PS, Tschetter LK, Rayson S. Randomized trial of dietician counseling to try to prevent weight gain associated with breast cancer adjuvant chemotherapy. Oncology. 1996 May-Jun; 53(3):228-32.
    View PubMed
  262. Fidler P, Loprinzi CL, O'Fallon JR, Leitch JM, Lee JK, Hayes DL, Novotny P, Clemens-Schutjer D, Bartel J, Michalak JC. Prospective evaluation of a chamomile mouthwash for prevention of 5-FU-induced oral mucositis. Cancer. 1996 Feb 1; 77(3):522-5.
    View PubMed
  263. Rowland KM Jr, Loprinzi CL, Shaw EG, Maksymiuk AW, Kuross SA, Jung SH, Kugler JW, Tschetter LK, Ghosh C, Schaefer PL, Owen D, Washburn JH Jr, Webb TA, Mailliard JA, Jett JR. Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study. J Clin Oncol. 1996 Jan; 14(1):135-41.
    View PubMed
  264. Loprinzi CL. Management of menopausal symptoms in breast cancer survivors. ASCO Spring Educational Book. 1996.
  265. Loprinzi CL. North Central Cancer Treatment Group (NCCTG). J Natl Cancer Inst Monogr. 1996; 20:79-80.
    View PubMed
  266. Loprinzi CL, Smith TJ. Surveillance testing in curatively-treated cancer survivors. ASCO Educational Book. 1996:29-32.
  267. Loprinzi C, Messing E, O'Fallon J, Poon M, Love R, Quella S, Trump D, Morton R, Novotny P Toxicity evaluation of difluoromethylornithine (DFMO): Doses for chemoprevention trials Cancer Epidemiology Biomarkers and Prevention. 1996; 5:371-374.
    View PubMed
  268. Weiss M, Loprinzi CL, Creagan ET, Dalton RJ, Novotny P, O'Fallon JR. Utility of follow-up tests for detecting recurrent disease in patients with malignant melanomas. JAMA. 1995 Dec 6; 274(21):1703-5.
    View PubMed
  269. Loprinzi CL, Peethambaram PP. Management of menopausal symptoms in breast cancer patients. Ann Med. 1995 Dec; 27(6):653-6.
    View PubMed
  270. Goldberg RM, Loprinzi CL, Mailliard JA, O'Fallon JR, Krook JE, Ghosh C, Hestorff RD, Chong SF, Reuter NF, Shanahan TG. Pentoxifylline for treatment of cancer anorexia and cachexia? A randomized, double-blind, placebo-controlled trial. J Clin Oncol. 1995 Nov; 13(11):2856-9.
    View PubMed
  271. Loprinzi CL, Foote RL, Michalak J. Alleviation of cytotoxic therapy-induced normal tissue damage. Semin Oncol. 1995 Apr; 22(2 Suppl 3):95-7.
    View PubMed
  272. Wilwerding MB, Loprinzi CL, Mailliard JA, O'Fallon JR, Miser AW, Vanhaelst C, Barton DL, Foley JF, Athmann LM. A randomized crossover evaluation of methyphenidate in cancer patients receiving strong narcotics. Support Care Cancer. 1995 Mar; 3:135-8.
    View PubMed
  273. Loprinzi CL. Management of cancer anorexia/cachexia. Support Care Cancer. 1995 Mar; 3(2):120-2.
    View PubMed
  274. Loprinzi CL. How to manage cancer anorexia/cachexia. Contemporary Oncology Cancer, and HIV-Associated Anorexia and , Evaluation, and Management (Suppl)11-3. 1995 Mar; Cachexia:Mechanisms.
  275. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, Bate WW, Rospond RM, Oesterling JE. Megestrol acetate for the prevention of hot flashes. Obstet Gynecol Surv. 1995 Feb; 50(2):135-137.
  276. Au E, Loprinzi CL, Dhodapkar M, Nelson T, Novotny P, Hammack J, O'Fallon J. Regular use of a verbal pain scale improves the understanding of oncology inpatient pain intensity. J Clin Oncol. 1994 Dec; 12(12):2751-5.
    View PubMed
  277. Foote RL, Loprinzi CL, Frank AR, O'Fallon JR, Gulavita S, Tewfik HH, Ryan MA, Earle JM, Novotny P. Randomized trial of a chlorhexidine mouthwash for alleviation of radiation-induced mucositis. J Clin Oncol. 1994 Dec; 12(12):2630-3.
    View PubMed
  278. Quella S, Loprinzi CL, Dose AM. A qualitative approach to defining "hot flashes" in men. Urol Nurs. 1994 Dec; 14(4):155-8.
  279. Ingle JN, Kuross SA, Mailliard JA, Loprinzi CL, Jung SH, Nelimark RA, Krook JE, Long HJ. Evaluation of piroxantrone in women with metastatic breast cancer and failure on nonanthracycline chemotherapy. Cancer. 1994 Sep 15; 74(6):1733-8.
    View PubMed
  280. Loprinzi CL, Michalak JC, Quella SK, O'Fallon JR, Hatfield AK, Nelimark RA, Dose AM, Fischer T, Johnson C, Klatt NE, et al. Megestrol acetate for the prevention of hot flashes. N Engl J Med. 1994 Aug 11; 331(6):347-52.
    View PubMed
  281. Loprinzi CL, Wender DB, Veeder MH, O'Fallon JR, Vaught NL, Dose AM, Ghosh C, Bartel J, Leitch JM. Inhibition of 5-fluorouracil-induced ocular irritation by ocular ice packs. Cancer. 1994 Aug 1; 74(3):945-8.
    View PubMed
  282. Loprinzi CL, Ravdin PM, de Laurentiis M, Novotny P. Do American oncologists know how to use prognostic variables for patients with newly diagnosed primary breast cancer? J Clin Oncol. 1994 Jul; 12(7):1422-6.
    View PubMed
  283. Loprinzi CL, Kuross SA, O'Fallon JR, Gesme DH Jr, Gerstner JB, Rospond RM, Cobau CD, Goldberg RM. Randomized placebo-controlled evaluation of hydrazine sulfate in patients with advanced colorectal cancer. J Clin Oncol. 1994 Jun; 12(6):1121-5.
    View PubMed
  284. Loprinzi CL, Goldberg RM, Su JQ, Mailliard JA, Kuross SA, Maksymiuk AW, Kugler JW, Jett JR, Ghosh C, Pfeifle DM, et al. Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer. J Clin Oncol. 1994 Jun; 12(6):1126-9.
    View PubMed
  285. Miser AW, Goh TS, Dose AM, O'Fallon JR, Niedringhaus RD, Betcher DL, Simmons P, MacKellar DJ, Arnold M, Loprinzi CL. Trial of a topically administered local anesthetic (EMLA cream) for pain relief during central venous port accesses in children with cancer. J Pain Symptom Manage. 1994 May; 9(4):259-64.
    View PubMed
  286. Hammack JE, Loprinzi CL. Use of orally administered opioids for cancer-related pain. Mayo Clin Proc. 1994 Apr; 69(4):384-90.
    View PubMed
  287. Loprinzi CL, Laurie JA, Wieand HS, Krook JE, Novotny PJ, Kugler JW, Bartel J, Law M, Bateman M, Klatt NE, et al. Prospective evaluation of prognostic variables from patient-completed questionnaires. North Central Cancer Treatment Group. J Clin Oncol. 1994 Mar; 12(3):601-7.
    View PubMed
  288. Loprinzi CL, Goldberg RM, O'Fallon JR, Quella SK, Miser AW, Mynderse LA, Brown LD, Tschetter LK, Wilwerding MB, Dose M, et al. Transdermal clonidine for ameliorating post-orchiectomy hot flashes. J Urol. 1994 Mar; 151(3):634-6.
    View PubMed
  289. Goldberg RM, Loprinzi CL, O'Fallon JR, Veeder MH, Miser AW, Mailliard JA, Michalak JC, Dose AM, Rowland KM Jr, Burnham NL. Transdermal clonidine for ameliorating tamoxifen-induced hot flashes. J Clin Oncol. 1994 Jan; 12(1):155-8.
    View PubMed
  290. Loprinzi CL. Phase III cancer chemoprevention trials: how do they contrast with cancer treatment trials? ASCO Educational Book. 1994; 29-33.
  291. Hammack J, Loprinzi C Use of orally administered opioids for cancer-related pain Mayo Clinic Proc. 1994; 69:384-390.
    View PubMed
  292. Loprinzi C Phase III cancer chemoprevention trials: How do they contrast with cancer treatment trials? Proc Am Soc Clin Oncol. 1994:29-33.
    View PubMed
  293. Rocke LK, Loprinzi CL, Lee JK, Kunselman SJ, Iverson RK, Finck G, Lifsey D, Glaw KC, Stevens BA, Hatfield AK. A randomized clinical trial of two different durations of oral cryotherapy for prevention of 5-fluorouracil-related stomatitis. Cancer. 1993 Oct 1; 72(7):2234-8.
    View PubMed
  294. Creagan ET, Schaid DJ, Hartmann LC, Loprinzi CL. A phase II study of 5,6-dihydro-5-azacytidine hydrochloride in disseminated malignant melanoma. Am J Clin Oncol. 1993 Jun; 16(3):243-4.
    View PubMed
  295. Loprinzi CL, Michalak JC, Schaid DJ, Mailliard JA, Athmann LM, Goldberg RM, Tschetter LK, Hatfield AK, Morton RF. Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia. J Clin Oncol. 1993 Apr; 11(4):762-7.
    View PubMed
  296. Loprinzi CL, Duffy J, Ingle JN. Postchemotherapy rheumatism. J Clin Oncol. 1993 Apr; 11(4):768-70.
    View PubMed
  297. Ahlquist DA, Wieand HS, Moertel CG, McGill DB, Loprinzi CL, O'Connell MJ, Mailliard JA, Gerstner JB, Pandya K, Ellefson RD. Accuracy of fecal occult blood screening for colorectal neoplasia. A prospective study using Hemoccult and HemoQuant tests. JAMA. 1993 Mar 10; 269(10):1262-7.
    View PubMed
  298. Loprinzi CL, Schaid DJ, Dose AM, Burnham NL, Jensen MD. Body-composition changes in patients who gain weight while receiving megestrol acetate. J Clin Oncol. 1993 Jan; 11(1):152-4.
    View PubMed
  299. Davis T, Miser AW, Loprinzi CL, Kaur JS, Burnham NL, Dose AM, Ames MM. Comparative morphine pharmacokinetics following sublingual, intramuscular, and oral administration in patients with cancer. Hosp J. 1993; 9(1):85-90.
    View PubMed
  300. Loprinzi CL. Pharmacologic management of cancer anorexia/cachexia. Oncology. 1993; 7:101-103.
  301. Loprinzi CL, O'Fallon JR. Symptom control research in a cooperative oncology group. Advances in Medical Psychotherapy. 1993; 6:241-246.
  302. Loprinzi CL, Jensen MD, Jiang NS, Schaid DJ. Effect of megestrol acetate on the human pituitary-adrenal axis. Mayo Clin Proc. 1992 Dec; 67(12):1160-2.
    View PubMed
  303. Pisansky TM, Schaid DJ, Loprinzi CL, Donohue JH, Schray MF, Schomberg PJ. Inflammatory breast cancer: integration of irradiation, surgery, and chemotherapy. Am J Clin Oncol. 1992 Oct; 15(5):376-87.
    View PubMed
  304. Loprinzi CL, Goldberg RM, Burnham NL. Cancer-associated anorexia and cachexia. Implications for drug therapy. Drugs. 1992 Apr; 43(4):499-506.
    View PubMed
  305. Loprinzi CL, Messing EM. A prospective clinical trial of difluoromethylornithine (DFMO) in patients with resected superficial bladder cancer. J Cell Biochem Suppl. 1992; 16I:153-5.
    View PubMed
  306. Loprinzi CL, Goldberg RM, Burnham N. Cancer - associated anorexia and cachexia: implications for drug therapy. New Ethicals. 1992; 29:125-131.
  307. Loprinzi CL, Johnson PA, Jensen M. Megestrol acetate for anorexia and cachexia. Oncology. 1992; 49 Suppl 2:46-9.
    View PubMed
  308. Witzig TE, Loprinzi CL, Gonchoroff NJ, Reiman HM, Cha SS, Wieand HS, Katzmann JA, Paulsen JK, Moertel CG. DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages b2 colorectal adenocarcinoma. Cancer. 1991 Aug 15; 68:879-888.
    View PubMed
  309. Ingle JN, Mailliard JA, Schaid DJ, Krook JE, Gesme DH Jr, Windschitl HE, Pfeifle DM, Etzell PS, Gerstner JG, Long HJ, et al. A double-blind trial of tamoxifen plus prednisolone versus tamoxifen plus placebo in postmenopausal women with metastatic breast cancer. A collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic. Cancer. 1991 Jul 1; 68(1):34-9.
    View PubMed
  310. Mahood DJ, Dose AM, Loprinzi CL, Veeder MH, Athmann LM, Therneau TM, Sorensen JM, Gainey DK, Mailliard JA, Gusa NL, Goldberg R. Inhibition of fluorouracil-induced stomatitis by oral cryotherapy. J Clin Oncol. 1991 Mar; 9(3):449-52.
    View PubMed
  311. Ransom DT, Neuberg D, Loprinzi CL, Tormey DC, Blum RH, Harris JE, Asbury RF, Falkson G. A pilot study of three sequential chemotherapeutic regimens in metastatic breast cancer. Am J Clin Oncol. 1991 Feb; 14(1):45-8.
    View PubMed
  312. Loprinzi CL, Ingle JN, Schaid DJ, Buckner JC, Edmonson JH, Allegra CJ. 5-Fluorouracil plus leucovorin in women with metastatic breast cancer. A phase II study. Am J Clin Oncol. 1991 Feb; 14(1):30-2.
    View PubMed
  313. Loprinzi CL, Ellison NM, Goldberg RM, Michalak JC, Burch PA. Alleviation of cancer anorexia and cachexia: studies of the Mayo Clinic and the North Central Cancer Treatment Group. Semin Oncol. 1990 Dec; 17(6 Suppl 9):8-12.
    View PubMed
  314. Camoriano JK, Loprinzi CL, Ingle JN, Therneau TM, Krook JE, Veeder MH. Weight change in women treated with adjuvant therapy or observed following mastectomy for node-positive breast cancer. J Clin Oncol. 1990 Aug; 8(8):1327-34.
    View PubMed
  315. Loprinzi CL, Ellison NM, Schaid DJ, Krook JE, Athmann LM, Dose AM, Mailliard JA, Johnson PS, Ebbert LP, Geeraerts LH. Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia. J Natl Cancer Inst. 1990 Jul 4; 82(13):1127-32.
    View PubMed
  316. Ames MM, Loprinzi CL, Collins JM, van Haelst-Pisani C, Richardson RL, Rubin J, Moertel CG. Phase I and clinical pharmacological evaluation of pirozantrone hydrochloride (oxantrazole). Cancer Res. 1990 Jul 1; 50(13):3905-9.
    View PubMed
  317. Kardinal CG, Loprinzi CL, Schaid DJ, Hass AC, Dose AM, Athmann LM, Mailliard JA, McCormack GW, Gerstner JB, Schray MF. A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia. Cancer. 1990 Jun 15; 65(12):2657-62.
    View PubMed
  318. Loprinzi CL, Cianflone SG, Dose AM, Etzell PS, Burnham NL, Therneau TM, Hagen L, Gainey DK, Cross M, Athmann LM, et al. A controlled evaluation of an allopurinol mouthwash as prophylaxis against 5-fluorouracil-induced stomatitis. Cancer. 1990 Apr 15; 65(8):1879-82.
    View PubMed
  319. Krook JE, Loprinzi CL, Schaid DJ, Kardinal CG, Mailliard JA, Pfeifle DM, Ellison NM, Reuter NF, Nelimark RA. Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase II study. Cancer. 1990 Feb 1; 65(3):418-21.
    View PubMed
  320. Loprinzi CL, Dose AM. Studies on the prevention of 5-fluorouracil-induced oral mucositis. NCI Monogr. 1990; (9):93-4.
    View PubMed
  321. Coltman CA, Abrams JS, Aisner J, Cruz JM, Hellerstein MK, Loprinzi CL, Paterson AHG, Schacter LP, Von Roenn JH. Therapy to promote weight gain in cancer and acquired immunodeficiency syndrome patients: a panel discussion (part I). Semin Oncol. 1990; 17:34-37.
  322. Loprinzi CL, Love RR, Garrity JA, Ames MM. Cyclophosphamide, methotrexate, and 5-fluorouracil (CMF)-induced ocular toxicity. Cancer Invest. 1990; 8(5):459-65.
    View PubMed
  323. Edmonson JH, Buckner JC, Long HJ, Loprinzi CL, Schaid DJ. Phase II study of ifosfamide-etoposide-mesna in adults with advanced nonosseous sarcomas. J Natl Cancer Inst. 1989 Jun 7; 81(11):863-6.
    View PubMed
  324. Loprinzi CL. 5-Fluorouracil with leucovorin in breast cancer. Cancer. 1989 Mar 15; 63(6 Suppl):1045-7.
    View PubMed
  325. Loprinzi CL, Miser AW, Kardinal C, Everson LK, Ahlquist DA, Dose AM, Moertel CG. Cancer control research in the North Central Cancer Treatment Group (NCCTG). Prog Clin Biol Res. 1989; 293:345-53.
    View PubMed
  326. Loprinzi CL, Burnham NL, O'Connell MJ, Svingen PA, Peterson DA. Allopurinol mouthwash kinetic and stability information based on normal volunteers. Hosp Pharm. 1989; 24:353-354.
  327. Gallenberg MM, Loprinzi CL. Breast cancer in pregnancy. Semin Oncol. 1989; 16:369-376.
    View PubMed
  328. Loprinzi CL, Rasmussen PW, Tormey DC, Carbone PP. Combined modality treatment of local-regionally advanced breast cancer patients: five to ten year follow up. Am J Clin Oncol. 1989; 12:208-212.
    View PubMed
  329. Loprinzi CL, Love RR, Therneau TM, Verman AK. Inhibition of human skin ornithine decarboxylase activity by oral alpha-diflouromethylornithine. Cancer Therapy and Control. 1989; 1:75-80.
  330. Loprinzi C, Miser A, Kardinal C, Everson L, Ahlquist D, Dose A, Moertel C Advances in Cancer Control: Innovations & Research Cancer control research in the North Central Cancer Treatment Group. 1989:345-353.
    View PubMed
  331. Creagan ET, Loprinzi CL, Ahmann DL, Schaid DJ. A phase I-II trial of the combination of recombinant leukocyte A interferon and recombinant human interferon-gamma in patients with metastatic malignant melanoma. Cancer. 1988 Dec 15; 62(12):2472-4.
    View PubMed
  332. Long HJ, Schaid DJ, Schutt AJ, Ingle JN, Loprinzi CL, Edmonson JH. Phase II evaluation of menogaril in women with metastatic breast cancer after failure of first-line chemotherapy. Am J Clin Oncol. 1988 Oct; 11(5):524-7.
    View PubMed
  333. Loprinzi CL, Ingle JN, Schaid DJ, Buckner JC, Edmonson JH. Progress report on a phase II trial of 5-fluorouracil plus citrovorum factor in women with metastatic breast cancer. Adv Exp Med Biol. 1988; 244:255-9.
    View PubMed
  334. Richardson RL, Schutt AJ, O'Connell MJ, Creagan ET, Loprinzi CL, Powis G. Phase I study of amonafide (a) (nsc-308847) given by 24-hour continuous intravenous infusion (24h-civ) every 4 weeks. Proc Annu Meet Am Soc Clin Oncol. 1987 Mar; 6:35.
  335. Loprinzi CL, Tormey DC, Rasmussen P, Falkson G, Davis TE, Falkson HC, Chang AY. Prospective evaluation of carcinoembryonic antigen levels and alternating chemotherapeutic regimens in metastatic breast cancer. J Clin Oncol. 1986 Jan; 4(1):46-56.
    View PubMed
  336. Loprinzi CL, Verma AK. Dose and schedule of oral retinoic acid and indomethacin needed to effectively inhibit phorbol ester-induced epidermal ornithine decarboxylase activity. Carcinogenesis. 1985 Nov; 6(11):1589-92.
    View PubMed
  337. Verma AK, Loprinzi CL, Boutwell RK, Carbone PP. In vitro induction of human skin ornithine decarboxylase by the tumor prompter 12-0-tetradecanoylphorbol-13-acetate. J Natl Cancer Inst. 1985 Jul; 75:85-90.
    View PubMed
  338. Loprinzi CL, Verma AK, Boutwell RK, Carbone PP. Inhibition of phorbol ester-induced human epidermal ornithine decarboxylase activity by oral compounds: a possible role in human chemoprevention studies. J Clin Oncol. 1985; 3:751-756.
    View PubMed
  339. Loprinzi CL, Verma AK. Studies on the dose and schedule of alpha-difluoromethylornithine needed to inhibit ornithine decarboxylase activity in mice. Cancer Lett. 1985; 28:327-333.
    View PubMed
  340. Loprinzi CL, Verma AK. Effects of local anesthetics on phorbol ester-induced ornithine decarboxylase activity in mouse and human skin. Anticancer Res. 1984 Nov-Dec; 4(6):363-6.
    View PubMed
  341. Trump DL, Loprinzi CL. Phase II trial of etoposide in advanced prostate cancer. Cancer Treat Rep. 1984 Sep; 68(9):1195-6.
    View PubMed
  342. Davis TE, Loprinzi CL, Buchler DA. Combination chemotherapy with cisplatin, vinblastine, and bleomycin for endodermal sinus tumor of the ovary. Gynecol Oncol. 1984 Sep; 19(1):46-52.
    View PubMed
  343. Loprinzi CL, Carbone PP, Tormey DC, Rosenbaum PR, Caldwell W, Kline JC, Steeves RA, Ramirez G. Aggressive combined modality therapy for advanced local-regional breast carcinoma. J Clin Oncol. 1984 Mar; 2(3):157-63.
    View PubMed
  344. Loprinzi CL. Mitomycin C induced pulmonary and renal toxicity. Wis Med J. 1984; 83:16-17.
    View PubMed
  345. Jaffe JP, Loprinzi CL. Basophilic-eosinophilic meningitis in an undifferentiated myeloproliferative disorder. JAMA. 1983 Jan 7; 249(1):73-4.
    View PubMed
  346. Loprinzi CL, Heaton JW Jr, Kelly PC. Enterohepatic fistulas associated with amebic liver abscesses. South Med J. 1983; 76:384-386.
    View PubMed
  347. Loprinzi CL, Hennessee J, Tamsky L, Johnson TE. Snake antivenom administration in a patient allergic to horse serum. South Med J. 1983; 76:501-502.
    View PubMed
  348. Loprinzi CL. Prostatic cancer. South Med J. 1982 Feb; 75(2):193-6.
    View PubMed